- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Zogenix Inc+ Add to Watchlist
ZGNX:US1.8800 USD 0.1400 8.05%
As of 16:00:00 ET on 03/06/2015.
Company Profile for Zogenix Inc (ZGNX)
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
Key Executives for Zogenix Inc (ZGNX)
|Roger L HawleyCEO/Interim Chief Commercial Ofcr||Stephen J FarrPresident/Co-Founder|
|Ann D RhoadsExec VP/CFO/Treasurer/Secy||Bradley Stuart Galer "Brad Gale"Exec VP/Chief Medical Officer|
|John J TuraninVP & General Mgr:Zogenix Tech||Bret E MegargelVP:Corporate Dev/Co-Founder|
|Stephen H JennerVP:Marketing||Edward F Smith IIIVP:Regulatory Affairs & Drug|
|Mark R ThompsonVP:Sales & Managed Markets||Jeff D DurflingerVP:Technical Ops & Product|
|Arnold R GammaitoniVP:Medical & Scientific Affairs|